Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice

S. Consigny, A. Bentoucha, P. Bonnafous, J. Grosset, B. Ji

Research output: Contribution to journalArticle

Abstract

Bactericidal activities of HMR 3647 (HMR), moxifloxacin (MXFX), and rifapentine (RPT) against Mycobacterium leprae, measured by the proportional bactericidal technique in the mouse footpad system, were compared with those of the established antileprosy drugs clarithromycin (CLARI), ofloxacin (OFLO), and rifampin (RMP). Administered in five daily doses of 100 mg/kg of body weight, HMR appeared slightly more bactericidal than CLARI. In a single dose, MXFX at 150 mg/kg was more active than the same dose of OFLO and displayed exactly the same level of activity as RMP at 10 mg/kg; the combination MXFX-minocycline (MINO) (MM) was more bactericidal than the combination OFLO-MINO (OM); RPT at 10 mg/kg was more bactericidal than the same dose of RMP and even more active than the combination RMP-OFLO-MINO (ROM); the combination RPT-MKFX-MINO (PMM) killed 99.9% of viable M. leprae and was slightly more bactericidal than RPT alone, indicating that the combination PMM showed an additive effect against M. leprae.

Original languageEnglish (US)
Pages (from-to)2919-2921
Number of pages3
JournalAntimicrobial agents and chemotherapy
Volume44
Issue number10
DOIs
StatePublished - 2000

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice'. Together they form a unique fingerprint.

  • Cite this